www.thehindu.com Open in urlscan Pro
172.64.148.21 Public Scan

Back to summary

URL:
https://www.thehindu.com/news/national/nppa-directs-firms-to-cut-prices-of-three-anti-cancer-drugs/article68810641.ece
Submission: On November 08 via api (November 8th 2024, 8:21:36 am UTC) from IN — Scanned from DE

Form analysis
0 forms found in the DOM

Text Content

*
* India
* World
* Elections
* Technology
* e-Paper
* Menu

1. Science
2. Data
3. Opinion
4.
5. SEARCH

FREE TRIALGIFT a Subscription Subscribe LOGIN ACCOUNT PREMIUM

Open in The Hindu App
FREE TRIALLOGINGIFT a Subscription ACCOUNT PREMIUM

1. Science
2. Data
3. Opinion
4.
5. SEARCH

*
* India
* World
* Elections
* Technology
* e-Paper

1. Science
2. Data
3. Opinion
4.
5. SEARCH

* News
* Business
* Entertainment
* Life & Style
* Society
* Technology
* Videos
* Sport
* Cities
* States
* Science
* Show More

* Chennai
* Delhi
* Bengaluru
* Hyderabad
* Movies
* Food
* Children
* Data
* Kochi
* Books
* Education
* Podcast
* Brandhub

To enjoy additional benefits

FREE TRIALGIFT a Subscription Subscribe LOGIN ACCOUNT PREMIUM

read today's paper

read today's paper
ShowcaseSubscribe to NewslettersCrossword+

CONNECT WITH US

*
*
*
*
*
*
*
*

1. Home
2. News
3. India

NATIONAL PHARMACEUTICAL PRICING AUTHORITY DIRECTS FIRMS TO CUT PRICES OF THREE
ANTI-CANCER DRUGS

GOVT. HAD EARLIER SCRAPPED CUSTOMS DUTY ON TRASTUZUMAB, OSIMERTINIB AND
DURVALUMAB AND ALSO REDUCED GST RATES ON THEM

Updated - October 29, 2024 08:23 pm IST - NEW DELHI

Bindu Shajan Perappadan
* Copy link
* Email
* Facebook
* Twitter
* Telegram
* LinkedIn
* WhatsApp
* Reddit

1 / 1 New
READ LATER
Remove SEE ALL
PRINT

Manufacturers are required to issue a price list or supplementary price list
indicating changes, and submit information regarding price change to the pharma
pricing regulator. | Photo Credit: Getty Images/iStockphoto

The National Pharmaceutical Pricing Authority (NPPA) has directed manufacturers
to reduce the maximum retail price (MRP) of three anti-cancer drugs –
Trastuzumab, Osimertinib and Durvalumab – in line with the government’s
commitment to ensure the availability of drugs at affordable prices.

Anti-cancer jab taking 7 minutes to administer rolled out in England

“This is in pursuance of the announcement made in the Union Budget for the year
2024-25 exempting these three anti-cancer medicines from customs duty. The
Department of Revenue, Ministry of Finance, issued a notification recently
reducing the customs duty on these three drugs to nil,’’ said a release issued
by the Central government on Tuesday (October 29, 2024).

Further, the Department of Revenue had issued a notification reducing the GST
rates on the three drugs from 12% to 5% with effect from October 10, 2024.

“Accordingly, there should be a reduction in the MRP of these drugs in the
market, and the benefits of reduced taxes and duties should be passed on to the
consumers,’’ said the release.

Hence the NPPA issued the present directive. The manufacturers are required to
issue a price list or supplementary price list to the dealers, State Drugs
Controllers and the government indicating the changes, and submit information
regarding price change to the NPPA through the relevant forms (Form-II/
Form-V).

Published - October 29, 2024 08:03 pm IST

Read Comments 1 / 1 New
* Copy link
* Email
* Facebook
* Twitter
* Telegram
* LinkedIn
* WhatsApp
* Reddit

READ LATER
Remove SEE ALL
PRINT

www.thehindu.com Open in urlscan Pro 172.64.148.21 Public Scan

Form analysis 0 forms found in the DOM

Text Content

www.thehindu.com Open in urlscan Pro
172.64.148.21 Public Scan

Form analysis
0 forms found in the DOM